1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2        Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3        Systemic Aspergillosis and Systemic Candidasis Market – By Country

2.           Systemic Aspergillosis and Systemic Candidasis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

4.4         Clinical Trials Phases of Products Offered by Companies

4.5         Candida Specific Marketed Products

5.           Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Fungal Diseases

5.1.2        Rising Hospital Acquired Fungal Infection

5.2         Market Restraints

5.2.1        Increasing Resistance to Antifungal Drugs

5.2.2        Side Effects of Antifungal Drugs

5.3         Market Opportunities

5.3.1        Increase in R&D Activities and Pipeline of New Drug

5.4         Future Trends

5.4.1        Consolidation of Market

5.5         Impact Analysis

6.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1         Overview

6.2         Europe Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3         Voriconazole

6.3.1        Overview

6.3.2        Europe Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4         Liposomal Amphotericin B

6.4.1        Overview

6.4.2        Europe Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5         Systemic Oral Azoles

6.5.1        Overview

6.5.2        Europe Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6         Topical Antifungal Agents

6.6.1        Overview

6.6.2        Europe Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Others

6.7.1        Overview

6.7.2        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1         Overview

7.2         Europe Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3         Chronic Pulmonary Aspergillosis (CPA)

7.3.1        Overview

7.3.2        Europe Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1        Overview

7.4.2        Europe Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Gastrointestinal Candidasis

7.5.1        Overview

7.5.2        Europe Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Genitourinary Tract Candidasis

7.6.1        Overview

7.6.2        Europe Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis

8.1         Systemic Aspergillosis and Systemic Candidasis Market

8.1.1        Overview

8.1.2        Europe: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.3        Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.4        Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.5        Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

8.1.6        Germany: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Germany: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Germany: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3          Germany: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.7        UK: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          UK: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          UK: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3          UK: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.8        France: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1          France: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2          France: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.8.3          France: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.9        Italy: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1          Italy: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2          Italy: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.9.3          Italy: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.10     Spain: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.10.1       Spain: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.10.2       Spain: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.10.3       Spain: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.11     Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.11.1       Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.11.2       Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.11.3       Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

9.           Impact of COVID-19 Pandemic on Europe Systemic Aspergillosis and Systemic Candidasis Market

9.1         Europe: Impact Assessment Of COVID-19 Pandemic

10.        COMPANY PROFILES

10.1      Novartis AG

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Sanofi

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      Pfizer Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Merck & Co., Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      Bayer AG

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      Astellas Pharma Inc.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      GlaxoSmithKline plc.

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Abbott

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9      Cipla Inc.

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     Key Developments

11.        Appendix

11.1      About the Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             Clinical Trials Phases of Products Offered by Companies

Table 2.             Candida Specific Marketed Products

Table 3.             Europe Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Europe Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             US: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027

Table 7.             UK: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             UK: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             France: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          France: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Italy: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Italy: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 17.          Glossary of Terms, Systemic Aspergillosis and Systemic Candidasis Market

LIST OF FIGURES

Figure 1.           Systemic Aspergillosis and Systemic Candidasis Market Segmentation

Figure 2.           Systemic Aspergillosis and Systemic Candidasis Market, By Country

Figure 3.           Europe Systemic Aspergillosis and Systemic Candidasis Market Overview

Figure 4.           Systemic Oral Azoles Segment Held Largest Share of Type Segment in Systemic Aspergillosis and Systemic Candidasis Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           PEST Analysis

Figure 7.           Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8.           Europe Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9.           Europe Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 10.        Europe Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Europe Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Europe others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Europe Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15.        Europe Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Europe Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Europe Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Europe others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Systemic Aspergillosis and Systemic Candidasis Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        Europe: Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        Europe: Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

Figure 23.        Germany: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        UK: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        France: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Italy: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Spain: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Rest of Europe: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)